Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treat-to-target olmesartan medoxomil with add-on hydrochlorothiazide and amlodipine in mild to moderate hypertension
2005-004659-36Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of olmesartan in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Target blood pressure achievement. Started Feb 2006; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2005-004659-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004659-36.